COVID made 2021 a huge transition year for Penny Heaton; she went from being CEO of the Bill & Melinda Gates Medical Research Institute to global therapeutic area head, vaccines at the Janssen Pharmaceutical Companies of Johnson & Johnson. Yet, the medically trained Heaton insists on a continuity of her mission: “I passionately believe in pushing science as far as possible to combat inequities in health, to ensure that everyone has the opportunity to lead a healthy and productive life, no matter where they live,” she states on her LinkedIn profile.
